Overview
- 47 inspections across 44 sites are on record.
- 160 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2021-12-17.
At a glance
Inspections
47
Sites
44
Observations
160
Career since
Dec 2015
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Rizwana Mohseni, DO | 17 Dec 2021 | Human Drugs | |
| Boston Scientific Corporation | 18 Nov 2021 | Medical Devices & Rad Health | View 483 → |
| Namsa | 21 Sep 2021 | Medical Devices & Rad Health | View 483 → |
| Geneva Laboratories, Inc | 23 Jul 2021 | Medical Devices & Rad Health | View 483 → |
| American Preclinical Services | 21 May 2021 | Medical Devices & Rad Health |
Sites inspected
Rizwana Mohseni, DOMontclair, United States1 insp.
Boston Scientific CorporationSaint Paul, United States1 insp.
NamsaMinneapolis, United States1 insp.
Geneva Laboratories, IncElkhorn, United States1 insp.
American Preclinical ServicesMinneapolis, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Sharon L Matson6 shared
Anthony J Ladner3 shared
Eric S Myskowski2 shared
Peter R Lenahan2 shared
Courtney R Tiegs2 shared
Linda Galindo1 shared
Hugh M Mcclure1 shared
Mark J Seaton1 shared
Corrine M Carter1 shared
Kellie L Thommes1 shared
Full investigator report
Get the verbatim findings behind Nicole C Victoria's 160 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site